Related Experiment Videos
Relationship between CacyBP/SIP expression and prognosis in astrocytoma.
Wei Zhao1, Chunlin Wang, Junyu Wang
1Department of Neurosurgery, Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai 200003, China.
Summary
Loss of calcyclin-binding protein (CacyBP/SIP) expression in astrocytoma is linked to higher grade and poorer patient survival. CacyBP/SIP may serve as a prognostic marker for astrocytoma progression.
Area of Science:
- Neuro-oncology
- Molecular Pathology
- Cancer Biomarkers
Background:
- Astrocytoma, particularly glioblastoma multiforme (GBM), remains a challenging malignancy with significant unmet needs in prognostic markers.
- Calcyclin-binding protein (CacyBP/SIP) is a protein implicated in cellular regulation, but its role in astrocytoma has not been fully elucidated.
Purpose of the Study:
- To investigate the expression patterns of CacyBP/SIP in astrocytoma tissues.
- To determine the prognostic significance of CacyBP/SIP expression in relation to overall survival of glioblastoma multiforme (GBM) patients.
- To explore the correlation between CacyBP/SIP and proliferating cell nuclear antigen (PCNA) expression.
Main Methods:
- Immunohistochemistry was employed to assess CacyBP/SIP expression in 77 astrocytoma tissue specimens.
- Statistical analyses, including univariate and multivariate Cox regression, were performed to evaluate prognostic value.
- Correlation analysis was conducted to assess the relationship between CacyBP/SIP and PCNA expression.
Main Results:
- A significant proportion (63.6%) of astrocytoma tumors exhibited loss of CacyBP/SIP expression.
- Loss of CacyBP/SIP expression was strongly associated with higher tumor histological grade and poorer patient survival.
- CacyBP/SIP expression was negatively correlated with PCNA, a marker of proliferation, and emerged as an independent prognostic factor for astrocytoma.
Conclusions:
- CacyBP/SIP appears to function as a negative regulator in astrocytoma development and progression.
- The loss of CacyBP/SIP expression serves as a potential predictive biomarker for poor prognosis in astrocytoma patients.
- Further research into CacyBP/SIP's role could lead to novel therapeutic strategies for astrocytoma.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...